Autoimmune processes are proving to be underlying or contributory causes of increasing numbers of serious human disorders, including diabetes mellitus, Graves' disease, myasthenia gravis and rheumatoid arthritis. This symposium focuses on the advances in our basic understanding of the immune response and its regulation that are enabling specific, rational immunotherapy to be developed for these diseases. The nature of intracellular and cell surface-derived self antigens is considered here. Studies of murine autoimmune myocarditis are described in which cardiac myosin is identified as the autoantigen. Competing theories of the generation of immune tolerance are discussed, together with the implications of current ideas about immunoregulatory networks and the question of whether autoimmunity is a state of over-activity of the immune system or one of under- activity. Other chapters consider the exploitation of the immunoregulatory network in the treatment of experimental interstitial nephritis and other autoimmune conditions. The contributions of interferons and of class II HLA antigen expression to autoimmunity are presented. Suggested links between autoimmunity and immunodeficiency, and between autoimmunity and genetic complement deficiency, are also debated. The use of monoclonal anti-Ia antibodies to treat animal models of human autoimmune conditions suggests a way forward therapeutically, and the symposium ends with an assessment of the future of the immunoregulatory approach to diseases such as antiglomerular membrane disease, the systemic vasculitides, rheumatoid arthritis and multiple sclerosis.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
This work focuses on the autoimmune processes that have now been proven to underlie a number of serious diseases, including diabetes mellitus, rheumatoid arthritis and multiple sclerosis. Papers explore the rapidly expanding developments in research on immune response and regulation, and their potential in the development of treatments for autoimmune diseases. The wide range of subjects covered here include: the nature of intracellular and cell surface–derived ``self′′ antigens; competing theories of the generation of immune tolerance and their implications of current theories for research and treatment; possible links between autoimmunity and genetic complement deficiency; the contributions of interferons and class II HLA antigen expression to autoimmunity; and the potential of monoclonal antibodies and other biotechnological advances in treating human autoimmune conditions.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : PsychoBabel & Skoob Books, Didcot, Royaume-Uni
hardcover. Etat : Very Good. Etat de la jaquette : No Dust Jacket. First Edition. light shelf wear. Used. N° de réf. du vendeur 174241
Quantité disponible : 1 disponible(s)
Vendeur : Antiquariat Fluck, Berlin, Allemagne
Original-Pappband; Gr. 8°; ix (i) 278 Seiten. Sehr gutes Exemplar. Sprache: Englisch Ciba Foundation Symposium 129. 640 gr. N° de réf. du vendeur 48430
Quantité disponible : 1 disponible(s)
Vendeur : Buchpark, Trebbin, Allemagne
Etat : Sehr gut. Zustand: Sehr gut | Seiten: 288 | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar. N° de réf. du vendeur 37892882/202
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Hardcover. Etat : Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA77304719109536
Quantité disponible : 1 disponible(s)